Geoff S Higgins

10PUBLICATIONS
128CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisPredictive and prognostic markersRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 13, 2026
The pharmacological profile of ART6043, a first-in-class clinical DNA polymerase theta polymerase domain inhibitor potentiating PARP inhibitor efficacy.

|Jun 12, 2026
SHLD2 loss is a synthetic vulnerability to Polθ inhibition combined with radiotherapy.

|Apr 30, 2026
Structure-guided optimisation of fenofibrate-derived oxidative phosphorylation inhibitors to modify tumour hypoxia.

|Jan 24, 2025
Translation of PET radiotracers for cancer imaging: recommendations from the National Cancer Imaging Translational Accelerator (NCITA) consensus meeting.

Martina A McAteer, Daniel R McGowan, Gary J R Cook

|Sep 06, 2024
Combined Oxygen-Enhanced MRI and Perfusion Imaging Detect Hypoxia Modification from Banoxantrone and Atovaquone and Track Their Differential Mechanisms of Action.

James P B O'Connor, Victoria Tessyman, Ross A Little

|Aug 21, 2024
The Proteogenomics of Prostate Cancer Radioresistance.

Roni Haas, Gavin Frame, Shahbaz Khan

Pageof 2

Frequent Collaborators

4 joint publications

Robert A Heald

4 joint publications

Nicole Machado

3 joint publications

Helen M R Robinson

3 joint publications

Eeson Rajendra